A Product and Pipeline Analysis of the Global Immunoglobulin Market

Trends in Communicable and Non-Communicable Diseases Drug Pipeline

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

Immunoglobulin therapies are life-saving medicines that have been in use for more than 60 years. They provide the patient with a variety of antibodies and are often used as a last line of defense in many severe inflammatory diseases. In some conditions, they are life-saving. However, immunoglobulin therapies are expensive. Despite this, global demand for immunoglobulin is growing and the market is expected to foresee increased competition. As of 2015, more than 40 immunoglobulin treatments have been approved, with another 28 in various stages of development. This research service provides an overview of the marketed products and those in the pipeline. The analysis divides these treatments by the communicable and non-communicable diseases that they treat. In addition, key products and companies are profiled.

Table of Contents

Executive SummaryKey FindingsKey Findings (continued)Major MilestonesMajor Milestones (continued)Scope of the StudyIntroduction to the Immunoglobulin MarketImmunoglobulin OverviewClassification of ImmunoglobulinsClassification of Immunoglobulins (continued)Treatment GuidelinesTreatment Guidelines (continued)Market OverviewMarket Overview (continued)Market Overview (continued)Immunoglobulin Market—Marketed and Pipeline ProductsOverview of Drugs Overview of Drugs (continued)Competitive Landscape—Communicable Diseases TreatmentsCompetitive Landscape—Non-Communicable Diseases TreatmentsCommunicable Diseases Product AnalysisCommunicable Diseases Product OverviewMarketed Product Analysis Marketed Product Analysis (continued) Marketed Product Analysis (continued) Marketed Product Analysis (continued)Marketed Product Analysis (continued)Marketed Product Analysis (continued)Pipeline Product Analysis Pipeline Product Analysis (continued)Non-Communicable Diseases Product AnalysisNon-Communicable Diseases Product OverviewMarketed Product AnalysisMarketed Product Analysis (continued) Marketed Product Analysis (continued)Pipeline Product AnalysisPipeline Product Analysis (continued) Immunoglobulin Market—Product DashboardsHizentra—CSL BehringCivacir—BiotestFlebogamma 10%—GrifolsGAMUNEX-C—GrifolsPrivigen—CSL BehringVariZIG—CangeneHepabulin IV—SK HoldingsZutectra—BiotestHyperTET—GrifolsKey Companies in the Immunoglobulin MarketBaxter International Inc.Biotest AGChina Biologics Products, Inc.CSL Behring LimitedGrifolsOctapharma AGKedrion BiopharmaImmunoglobulin Market—Timeline of Key EventsEstimated Key Product Launch Timeline Approval DatesFuture of the Immunoglobulin MarketConclusions—Future of Immunoglobulin MarketLegal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.